CARDIFF ONCOLOGY, INC. (CRDF) Operating cash flow 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$37.9MFY2025 · since FY2016: -$31.0M → -$37.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.9M | -0.6% |
| FY2024 | -$37.7M | -22.0% |
| FY2023 | -$30.9M | +8.7% |
| FY2022 | -$33.8M | -46.8% |
| FY2021 | -$23.0M | -41.2% |
| FY2020 | -$16.3M | -23.0% |
| FY2019 | -$13.3M | -0.5% |
| FY2018 | -$13.2M | +43.3% |
| FY2017 | -$23.3M | +25.0% |
| FY2016 | -$31.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRDF financial trends
CRDF RevenueCRDF Net incomeCRDF Net marginCRDF Gross profitCRDF Gross marginCRDF Operating incomeCRDF Operating marginCRDF Free cash flowCRDF Capital expendituresCRDF Return on equityCRDF Stock buybacksCRDF Dividends paidCRDF Total assetsCRDF Total liabilitiesCRDF Shareholders’ equityCRDF overview →